Los Angeles Capital Management LLC Collegium Pharmaceutical, Inc Transaction History

Los Angeles Capital Management LLC

$24.2 Billion
Q4 2024

A detailed history of Los Angeles Capital Management LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Los Angeles Capital Management LLC holds 52,527 shares of COLL stock, worth $1.49 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

52,527

Previous 57,227 8.21%

Holding current value

$1.49 Million

Previous $2.21 Million 31.98%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 04, 2025	SELL	$28.61 - $41.86 $134,467 - $196,742	-4,700 Reduced 8.21%	52,527 $1.5 Million
Q3 2024 Nov 04, 2024	SELL	$31.4 - $39.07 $84,277 - $104,863	-2,684 Reduced 4.48%	57,227 $2.21 Million
Q2 2024 Aug 05, 2024	SELL	$31.36 - $39.99 $189,069 - $241,099	-6,029 Reduced 9.14%	59,911 $1.93 Million
Q1 2024 Apr 05, 2024	SELL	$31.23 - $40.91 $143,220 - $187,613	-4,586 Reduced 6.5%	65,940 $2.56 Million
Q4 2023 Feb 06, 2024	SELL	$21.16 - $30.8 $134,366 - $195,580	-6,350 Reduced 8.26%	70,526 $2.17 Million
Q3 2023 Nov 06, 2023	BUY	$21.23 - $24.28 $12,419 - $14,203	585 Added 0.77%	76,876 $1.72 Million
Q2 2023 Aug 03, 2023	BUY	$21.06 - $24.0 $105,784 - $120,552	5,023 Added 7.05%	76,291 $1.64 Million
Q1 2023 May 04, 2023	SELL	$23.0 - $29.88 $503,769 - $654,461	-21,903 Reduced 23.51%	71,268 $1.71 Million
Q4 2022 Feb 06, 2023	SELL	$16.14 - $23.55 $739,970 - $1.08 Million	-45,847 Reduced 32.98%	93,171 $2.16 Million
Q3 2022 Nov 02, 2022	BUY	$15.46 - $20.1 $249,215 - $324,012	16,120 Added 13.12%	139,018 $2.23 Million
Q2 2022 Aug 05, 2022	BUY	$14.22 - $20.88 $332,449 - $488,153	23,379 Added 23.49%	122,898 $2.18 Million
Q1 2022 May 06, 2022	BUY	$17.2 - $22.5 $1.34 Million - $1.75 Million	77,648 Added 355.03%	99,519 $2.03 Million
Q2 2021 Aug 05, 2021	SELL	$21.74 - $25.28 $26,087 - $30,336	-1,200 Reduced 5.2%	21,871 $517,000
Q1 2021 May 05, 2021	SELL	$19.25 - $26.1 $382,112 - $518,085	-19,850 Reduced 46.25%	23,071 $546,000
Q4 2020 Feb 04, 2021	SELL	$17.83 - $22.29 $28,438 - $35,552	-1,595 Reduced 3.58%	42,921 $860,000
Q3 2020 Nov 02, 2020	SELL	$15.78 - $20.82 $15,148 - $19,987	-960 Reduced 2.11%	44,516 $927,000
Q2 2020 Aug 05, 2020	BUY	$15.49 - $23.51 $125,716 - $190,807	8,116 Added 21.72%	45,476 $795,000
Q1 2020 May 04, 2020	BUY	$13.89 - $25.45 $518,930 - $950,812	37,360 New	37,360 $610,000
Q3 2018 Nov 05, 2018	SELL	$14.16 - $24.3 $227,976 - $391,230	-16,100 Closed	0 $0
Q2 2018 Jul 31, 2018	BUY	$21.79 - $28.29 $350,819 - $455,469	16,100 New	16,100 $384,000

Others Institutions Holding COLL

# of Institutions

246

Shares Held

37.2M

Call Options Held

59.3K

Put Options Held

9.5K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $970M
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Los Angeles Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Los Angeles Capital Management LLC with notifications on news.

Account

Los Angeles Capital Management LLC Collegium Pharmaceutical, Inc Transaction History